Provided by Tiger Trade Technology Pte. Ltd.

Tivic Health Systems, Inc.

0.7601
-0.0552-6.77%
Post-market: 0.7072-0.0529-6.96%16:31 EST
Volume:36.78K
Turnover:28.98K
Market Cap:1.92M
PE:-0.08
High:0.8400
Open:0.8153
Low:0.7500
Close:0.8153
52wk High:13.23
52wk Low:0.7500
Shares:2.53M
Float Shares:2.33M
Volume Ratio:1.34
T/O Rate:1.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.3002
EPS(LYR):-19.6785
ROE:-178.18%
ROA:-96.20%
PB:0.34
PE(LYR):-0.04

Loading ...

Tivic Schedules Follow-Up BARDA Meeting on Entolimod for Acute Radiation Syndrome

Reuters
·
Feb 18

BRIEF-Tivic Health Systems Enters Stock Purchase Agreement With Tumim Stone Capital

Reuters
·
Feb 10

Tivic Health Systems Inc - on Feb 6, Enters Stock Purchase Agreement With Tumim Stone Capital - SEC Filing

THOMSON REUTERS
·
Feb 10

Tivic Health Systems schließt Aktienkaufvereinbarung über bis zu 50 Millionen Dollar mit Tumim Stone Capital ab

Reuters
·
Feb 10

Tivic Health Presents Entolimod Data at BARDA TechWatch Meeting

Reuters
·
Jan 28

Tivic Health Showcases Entolimod Commercialization Strategy at DealFlow Discovery Conference

Reuters
·
Jan 26

Tivic Health CEO to Present Corporate Update at Emerging Growth Virtual Conference

Reuters
·
Jan 21

Tivic Health delivers 200x scale-up in manufacturing for entolimod

TIPRANKS
·
Jan 12

Tivic Health Scales Up Entolimod Manufacturing with Velocity Bioworks Acquisition

Reuters
·
Jan 12

Tivic Health Acquires CDMO Assets to Accelerate Drug Development

Reuters
·
Jan 08

Tivic Health Systems Inc. Announces Date for Upcoming Special Stockholders Meeting

Reuters
·
Dec 30, 2025

Tivic Health Secures $16M Debt Financing Led by 3i for Manufacturing Asset Acquisition

Reuters
·
Dec 11, 2025

Tivic Health Shares Rise After US Agency Meeting on Entolimod Set

MT Newswires Live
·
Nov 19, 2025

Tivic Health secures BARDA meeting for entolimod in ARS

TIPRANKS
·
Nov 18, 2025

Tivic Health Systems Shifts Focus to Biopharma Program

TIPRANKS
·
Nov 15, 2025

Tivic Health Systems Q3 EPS $(2.00) Up From $(3.93) YoY, Sales $146.000K Up From $126.000K YoY

Benzinga
·
Nov 15, 2025

Bioelectronic medicine maker Tivic Health's Q3 net loss widens

Reuters
·
Nov 15, 2025

BRIEF-Tivic Health Systems Q3 Net Income USD -2.596 Million

Reuters
·
Nov 15, 2025

Tivic Health Reports Q3 2025 Results and Advances Entolimod Development

Reuters
·
Nov 15, 2025

Tivic Health Systems Q3 Gross Profit USD -145 Thousand

THOMSON REUTERS
·
Nov 15, 2025